Ubs Group Ag ENLIVEN THERAPEUTICS INC Transaction History

Ubs Group Ag

  • $555 Billion
  • Q2 2025
Number of Shares
138,280
Previous 70,436 96.32%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025
BUY
N/A
67,844 Added 96.32%
138,280 $0
Q1 2025

May 13, 2025
SELL
N/A
-16,752 Reduced 19.21%
70,436 $0
Q4 2024

Feb 14, 2025
BUY
N/A
59,506 Added 214.96%
87,188 $0
Q3 2024

Nov 14, 2024
BUY
N/A
7,564 Added 37.6%
27,682 $0
Q2 2024

Aug 13, 2024
SELL
N/A
-6,717 Reduced 25.03%
20,118 $0
Q1 2024

May 13, 2024
BUY
N/A
26,835 New
26,835 $0
Q3 2023

Nov 09, 2023
BUY
N/A
24 Added 29.63%
105 $0
Q2 2023

Aug 11, 2023
SELL
N/A
-253 Reduced 75.75%
81 $0
Q1 2023

May 12, 2023
BUY
N/A
334 New
334 $0
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email